Key points are not available for this paper at this time.
The brain serotonin (5-hydroxytryptamine; 5-HT) system is a powerful modulator of emotional processes and a target of medications used in the treatment of psychiatric disorders. To evaluate the contribution of serotonin 5-HT1A receptors to the regulation of these processes, we have used gene-targeting technology to generate 5-HT1A receptor-mutant mice. These animals lack functional 5-HT1A receptors as indicated by receptor autoradiography and by resistance to the hypothermic effects of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Homozygous mutants display a consistent pattern of responses indicative of elevated anxiety levels in open-field, elevated-zero maze, and novel-object assays. Moreover, they exhibit antidepressant-like responses in a tail-suspension assay. These results indicate that the targeted disruption of the 5-HT1A receptor gene leads to heritable perturbations in the serotonergic regulation of emotional state. 5-HT1A receptor-null mutant mice have potential as a model for investigating mechanisms through which serotonergic systems modulate affective state and mediate the actions of psychiatric drugs.
Building similarity graph...
Analyzing shared references across papers
Loading...
Lora K. Heisler
University of Aberdeen
Hung-Ming Chu
Taipei Institute of Pathology
Thomas J. Brennan
Northwestern University
Proceedings of the National Academy of Sciences
University of California, San Francisco
Scripps Research Institute
Building similarity graph...
Analyzing shared references across papers
Loading...
Heisler et al. (Tue,) studied this question.
synapsesocial.com/papers/69e24b06caf46d2d8c86b711 — DOI: https://doi.org/10.1073/pnas.95.25.15049
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: